Patents by Inventor Amelie CROSET

Amelie CROSET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind to IL1RAP and uses thereof
    Patent number: 12492259
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Grant
    Filed: March 8, 2024
    Date of Patent: December 9, 2025
    Assignee: IGI THERAPEUTICS SA
    Inventors: Julie Macoin, Amelie Croset, Jeremy Loyau, Thierry Monney, Lamine Mbow, Marie-Agnes Doucey, Valentina Labanca
  • Antibodies that bind to IL1RAP and uses thereof
    Patent number: 12492260
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Grant
    Filed: March 8, 2024
    Date of Patent: December 9, 2025
    Assignee: IGI THERAPEUTICS SA
    Inventors: Julie Macoin, Amelie Croset, Jeremy Loyau, Thierry Monney, Lamine Mbow, Marie-Agnes Doucey, Valentina Labanca
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20250361310
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and may also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: June 4, 2025
    Publication date: November 27, 2025
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • DLL3-SPECIFIC BINDING CONSTRUCTS AND THEIR USE IN RADIOTHERAPY
    Publication number: 20250332297
    Abstract: The present invention relates to DLL3-specific binding constructs comprising a designed ankyrin repeat domain with binding specificity for DLL3, a connector, and a chelator capable of bonding to a radionuclide, such as Pb-212, as well as to such DLL3-specific binding constructs comprising a half-life extending moiety with binding specificity for serum albumin. The invention further relates to methods of producing such radio-labelled DLL3-specific binding constructs, pharmaceutical compositions comprising such constructs, and the use of such constructs or pharmaceutical compositions in methods for treating, imaging or diagnosing diseases, such as cancer.
    Type: Application
    Filed: January 30, 2025
    Publication date: October 30, 2025
    Inventors: Christian REICHEN, Francesca MALVEZZI, Amelie CROSET, Stefanie RIESENBERG, Amal SAIDI, Aaron SCHATZMANN, Julien TORGUE
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20240327530
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: March 8, 2024
    Publication date: October 3, 2024
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20240327531
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: March 8, 2024
    Publication date: October 3, 2024
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • Antibodies that bind to IL1RAP and uses thereof
    Patent number: 11970539
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and may also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: April 30, 2024
    Assignee: Ichnos Sciences SA
    Inventors: Julie Macoin, Amelie Croset, Jeremy Loyau, Thierry Monney, Lamine Mbow, Marie-Agnes Doucey, Valentina Labanca
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20220089754
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 24, 2022
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA